ACHTSAM study protocol: outreach diagnostics and assessment of tolerability in severe ME/CFS-a pilot study

Carmen Fricke1, Peter Deibert2, Philipp Maier3

  • 1Institut für Bewegungs- und Arbeitsmedizin, Universitätsklinikum Freiburg, Freiburg, Germany carmen.fricke@uniklinik-freiburg.de.

BMJ Open
|March 6, 2026
PubMed
Abstract

Insights

This study explored home-based diagnostics for severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). It found this approach feasible and tolerable for patients with severe ME/CFS, overcoming mobility challenges in research.

Area of Science:

  • Medical research
  • Clinical diagnostics
  • Patient-centered outcomes

Background:

  • Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, multisystem illness impacting physical and cognitive function, often post-viral.
  • Severely affected ME/CFS patients face research exclusion due to immobility and exertional intolerance.

Purpose of the Study:

  • To assess the feasibility and tolerability of home-based diagnostic methods for individuals with severe and very severe ME/CFS.
  • To identify methodological barriers in conducting research with this patient population.

Main Methods:

  • Prospective, non-interventional observational study design.
  • Phase 1: Remote patient identification via validated questionnaires.
  • Phase 2: In-home assessments including physiological, cognitive, and biological measures.

Main Results:

  • The study successfully investigated the feasibility and tolerability of home-based diagnostics in severe ME/CFS patients.
  • Identified key methodological considerations for future research in this population.

Conclusions:

  • Home-based diagnostics are a feasible and tolerable approach for studying severe ME/CFS patients.
  • This methodology can help overcome barriers related to patient immobility and exertional intolerance, improving research inclusivity.